Table 3.
M ± SD | Periodicity strength metrics | |||||
---|---|---|---|---|---|---|
Method 1 | Method 2 | Method 3 | Method 4 | Method 5 | ||
Waist circumference, in | 66.82 ± 35.10 | 0.28 | 0.27 | 0.25 | 0.30 | ‡ |
Systolic BP, mm Hg | 138.6 ± 17.13 | ‡ | ‡ | ‡ | ‡ | 0.57∗ |
Diastolic BP, mm Hg | 89 ± 16.32 | ‡ | ‡ | ‡ | ‡ | ‡ |
Total cholesterol, mg/dL | 177.4 ± 50.51 | 0.52† | 0.68∗∗ | 0.57∗ | 0.46† | 0.47† |
HDL cholesterol, mg/dL | 33.9 ± 11.76 | ‡ | ‡ | ‡ | ‡ | 0.51† |
LDL cholesterol, mg/dL | 109.7 ± 37.64 | 0.45† | 0.57∗ | 0.46† | 0.40 | 0.42 |
hs-CRP, mg/dL | 7.76 ± 5.60 | 0.47† | 0.38 | 0.30 | 0.53† | ‡ |
Triglycerides, mg/dL | 168.7 ± 74.06 | 0.77∗∗ | 0.86∗∗∗ | 0.81∗∗∗ | 0.75∗∗ | ‡ |
Plasma glucose, mg/dL | 117.2 ± 50.69 | ‡ | ‡ | ‡ | ‡ | ‡ |
Insulin, pmol/L | 44.58 ± 73.01 | ‡ | ‡ | ‡ | ‡ | ‡ |
Health-related quality of life | 47.25 ± 13.03 | 0.37 | 0.54∗ | 0.55∗ | 0.37 | 0.52† |
∗∗∗ P < 0.001; ∗∗ P < 0.01; ∗ P < 0.05; † P < 0.10; ‡ r < 0.25 and P > 0.0.
All models are adjusted for age, gender, race/ethnicity, leisure-time physical activity, insomnia symptoms, and intervention assignment.